Antibacterial efficacy of silver nanoparticles of different sizes, surface conditions and synthesis methods

References

• Baker C, Pradhan A, Pakstis L, Pochan DJ, Shah SI. 2005. Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol 5:244–249.
   PubMed Web of Science ®Google Scholar
• Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. 2005. In vitro cytotoxicity of nanoparticles in mammalian germ line stem cells. Toxicol Sci 88:412–419.
   PubMed Web of Science ®Google Scholar
• Cho KH, Park JE, Osaka T, Park SG. 2005. The study of antimicrobial activity and preservative effects of nanosilver ingredient. Electrochimica Acta 51:956–960.
   Web of Science ®Google Scholar
• Choi O, Deng KK, Kim NJ, Ross Jr. L, Surampalli RY, Hu Z. 2008. The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res 42:3066–3074.
   PubMed Web of Science ®Google Scholar
• Cioffi N, Ditaranto N, Torsi L, Sabbatini L. 2009. Approaches to synthesis and characterization of spherical and anisotropic copper nanomaterials. In: Kumar C, editor. Metallic nanomaterials. Vol. 1. Weinheim, DE: Wiley-VCH. pp 3–70.
   Google Scholar
• Collins YE, Stotzky G. 1989. Factors affecting the toxicity of heavy metals to microbes. In: Beveridge TJ, Doyle RJ, editors. Metal ions and bacteria. New York: John Wiley and Sons. pp 31–90.
   Google Scholar
• Dror-Ehre A, Mamane H, Belenkova T, Markovich G, Adin A. 2009. Silver nanoparticle-E. coli colloidal interaction in water and effect on E. coli survival. J Colloid Interface Sci 339:521–526.
   PubMed Web of Science ®Google Scholar
• Fubini B, Fengolio I, Tomatis M. 2007. Physicochemical characteristics of nanoparticles that determine potential toxicity. In: Monteiro-Riviere NA, Tran CL, editors. Nanotoxicology: Characterization, dosing and health effects. New York: Informa Healthcare. pp 59–70.
   Google Scholar
• Gong P, Li H, He X, Wang K, Hu J, Tan W, Zhang S, Yang X. 2007. Preparation and antibacterial activity of Fe3O4 Ag nanoparticles. Nanotechnology 18:285604–285610.
   Web of Science ®Google Scholar
• Holt KB, Bard AJ. 2005. Interaction of silver (I) ions with the respiratory chain of Escherichia coli: An electrochemical and scanning electrochemical microscopy study of the antimicrobial mechanism of micromolar Ag+. Biochemistry 44:13214–13223.
   PubMed Web of Science ®Google Scholar
• Hussain S, Hess K, Gearhart J, Geiss K, Schlager J. 2005. In vitro toxicity of nanoparticles in BRL3A rat liver cells. Toxicol In Vitro 19:975–983.
   PubMed Web of Science ®Google Scholar
• Li WR, Xie XB, Shi QS, Zeng HY, OU-Yang YS, Chen YB. 2010. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Micro Biotech 85:1115–1122.
   PubMed Web of Science ®Google Scholar
• Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Chen CM. 2006. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteome Res 5:916–924.
   PubMed Web of Science ®Google Scholar
• Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY, 2007. Antimicrobial effects of silver nanoparticles. Nanomed. Nanotechnol Biol Med 3:95–101.
   PubMed Web of Science ®Google Scholar
• Kvítek L, Panáček A, Soukupová J, Kolář M, Večeřová R, Prucek R, Holecová M, Zbořil R. 2008. Effect of surfactants and polymers on stability and antibacterial activity of silver nanoparticles (NPs). J Phys Chem C Nanomater Interfaces 112:5825–5834.
   Web of Science ®Google Scholar
• Monteiro-Riviere NA, Inman AO, Zhang LW. 2009. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 234:222–235.
   PubMed Web of Science ®Google Scholar
• Monteiro-Riviere NA, Oldenburg SJ, Inman AO. 2010. Interactions of aluminum nanoparticles with human epidermal keratinocytes. J Appl Toxicol 30:276–285.
   PubMed Web of Science ®Google Scholar
• Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, Yacaman MJ. 2005. The bactericidal effect of silver nanoparticles. Nanotechnology 16:2346–2353.
   PubMed Web of Science ®Google Scholar
• Moyer CA, Brentano L, Gravens DL, Margraf HW, Monafo WW Jr. 1965. Treatment of large human burns with 0.5% silver nitrate solution. Arch Surg 90:812–867.
   PubMedGoogle Scholar
• Pal S, Tak YK, Song JM. 2007. Does the antimicrobial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73:1712–1720.
   PubMed Web of Science ®Google Scholar
• Panáček A, Kvítek L, Prucek R, Kolář M, Večeřová R, Pizúrova N, Sharma V, Nevěčná T, Zbořil R. 2006. Silver colloid nanoparticles: Synthesis, characterization, and their antimicrobial activity. J Phys Chem B 110:16248–16253.
   PubMed Web of Science ®Google Scholar
• Ruparelia JP, Chatterjee AK, Duttagupta SP, Mukherji S. 2008. Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomaterialia 4:707–716.
   PubMed Web of Science ®Google Scholar
• Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. 2010. Evaluation of silver nanoparticle toxicity in vivo skin and in vitro keratinocytes. Environ Health Perspect 118:407–413.
   PubMed Web of Science ®Google Scholar
• Silver S. 2003. Bacterial silver resistance: Molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 27:341–353.
   PubMed Web of Science ®Google Scholar
• Smetana AB, Klabunde KJ, Marchin GR, Sorensen CM. 2008. Biocidal activity of nanocrystalline silver powders and particles. Langmuir 24:7457–7464.
   PubMed Web of Science ®Google Scholar
• Sondi I, Salopek-Sondi B. 2004. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275:177–182.
   PubMed Web of Science ®Google Scholar
• Stone V, Kinloch I. 2007. Nanoparticle interactions with biological systems and subsequent activation of intracellular signaling mechanisms. In: Monteiro-Riviere NA, Tran CL, editors. Nanotoxicology: Characterization, dosing and health effects. New York: Informa Healthcare. pp 351–368.
   Google Scholar
• The Project on Emerging Nanotechnologies. August 2009, posting date. Washington DC: Woodrow Wilson International Center for Scholars. Accessed from the website: http://www.nanotechproject.org/inventories/consumer/analysis_draft/.
   Google Scholar
• Wanger A. 2007. Disk diffusion test and gradient methodologies. In: Schwalbe R, Steele-Moore L, Goodwin AC, editors. Antimicrobial susceptibility testing protocols. Boca Raton, FL: CRC Press Taylor and Francis Group. pp 53–74.
   Google Scholar
• Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, Roszek B, Bisschops J, Gosens I, Van De Meent D, 2009. Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 3:109–138.
   Web of Science ®Google Scholar
• Wikler MA, Cockerill FR III, Bush K, Dudley MN, Eliopoulos GE, Hardy DJ, Hecht DW, Hindler JF, Patel JB, Powell M, 2008. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved standard – 8th ed. Wayne, PA: Clinical and Laboratory Standards Institute, document M07-A8.
   Google Scholar
• Xu XHN, Brownlow WJ, Kyriacou SV, Wan Q, Viola JJ. 2004. Real-time probing of membrane transport in living microbial cells using single nanoparticle optics and living cell imaging. Biochemistry 43:10400–10413.
   PubMed Web of Science ®Google Scholar